Comparison of Clinical Outcomes Following Gefitinib and Erlotinib Treatment in Non–Small-Cell Lung Cancer Patients Harboring an Epidermal Growth Factor Receptor Mutation in Either Exon 19 or 21
Keywords: جفیتینیب، ایرسا; Non–small-cell lung cancer; Gefitinib; Erlotinib; Epidermal growth factor receptor mutation